For CD4 +low T-cell percentage, only a decreasing trend was observed in the entire study cohort at two- and six-month follow-up ( Figure 1 E,F).
← all excerpts
Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.
1
—
—